SIFROL ER

Kraj: Indonezja

Język: indonezyjski

Źródło: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Składnik aktywny:

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE

Dostępny od:

BOEHRINGER INGELHEIM INDONESIA - Indonesia

INN (International Nazwa):

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE

Dawkowanie:

0.375 MG

Forma farmaceutyczna:

TABLET PELEPASAN LAMBAT

Sztuk w opakowaniu:

DUS, 3 ALUBLISTER @ 10 TABLET PELEPASAN LAMBAT

Wyprodukowano przez:

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG., GERMANY - Federal Republic of Germany

Data autoryzacji:

2020-11-05

Charakterystyka produktu

PT. BOEHRINGER LNGCLHCIM INDONESIA
DRUG REGULATORY AFFAIRS DEPT.
1.
BASIC
PRODUCT INFORMATION
No. 0186-16
25 July 2012
SIFROL
®
PRAMIPEXOLE
COMPOSITION
1 tablet contains
0.125, 0.25 mg
(S)-2-amino-4,5,6,
7-tetrahydro-6-propylamino-benzothiazole dihydrochloride
monohydrate equivalent to 0.088, 0.18 mg pramipexole base
Exciplents:
mannltol, maize starch, anhydrous colloidal silica, polyvidone,
magnesium stearate
1 extended-release tablet contains
0.375, 0.75 mg
(S)-2-amino-4,5,6,
7-tetrahydro-6-propylamino-benzothiazole dihydrochloride
monohydrate equivalent to 0.26, 0.52 mg pramipexole base
Exciplents .. :
hypromellose 2208, maize starch, carbomer 941, colloidal anhydrous
silica, magnesium stearate
INDICATION
SIFROL
G
tablets and extended-release tablets are indicated for the treatment
of the signs
and symptoms of idiopathic parkinson's disease when the effect of
levodopa wears off or
becomes inconsistent and fluctuations of the therapeutic effect occur
(end of dose "on
off" fluctuations). It may be used alone (without levodopa) or in
combination with
levodopa.
�
;
�����
�
blets are indicated for the symptomatic treatme
r
t
.
�
f
�
�
io
,
�
at
��
-
C-
�
e
�
_
t
,
I
�
-
��
..
�
�
.
�
.
�
.
�
I '
Uf d� �fl;.:
............ .
DOSAGE AND ADMINISTRATION
,L
_.r_
_0_
_.��!_
_0_
_E' :.�.�._
_0_
_.: .. _
_�.�! _
_.. _
_� _
_.... ._
_(All dose information refers to pramipexole salt form) _
j : , , q, :� ll
h
·.:
.....
••.
••
•
....
.....
.
.
.
.. .
I
PARKINSON 'S DISEASE
Tablets
The tablets should be taken orally, swallowed with water, and can be
taken either with or
without food.
The daily dosage is administered in equally divided doses 3x per day.
Remarks: Yellow (CCDS 0186·13), blue (CCDS 0186-14), green (CCDS
0186-15), orange (CCDS 0186-16)
SIFROL
I')
CCDS 0186-16_ Reg May 12